Kyowa Kirin provides update on application for istradefylline in Europe for the treatment of ‘OFF’ episodes in people livingwith Parkinson’s
Kyowa Kirin Co., Ltd. has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion for istradefylline as an… read more.
